Abbott Toxicology Alere Toxicology Iscreen Dip Card

The specific configuration (iScreen Dx Dip Cards, Single Dip Device) tests for Oxycodone (OXY100).

This device provides rapid, laboratory-accurate results in minutes, utilizing a simple dip-and-read procedure. A significant benefit is that this Oxycodone variant is CLIA Waived, which simplifies its use in many point-of-care settings.

Yes, the specific configuration of the Abbott Toxicology iScreen Dip Card currently available is CLIA Waived.

This designation is vital for immediate, on-site drug screening, as it simplifies regulatory compliance for point-of-care testing environments.

The CLIA Waived variant detects Oxycodone (OXY100) and is packaged as:

• iScreen Dx Dip Cards, Oxycodone (OXY100) Single Dip Device, 25/bx

Yes, the specific variant available, the iScreen Dx Dip Card for Oxycodone (OXY100) Single Dip Device, is CLIA Waived. This critical designation makes the product ideal for point-of-care environments requiring simplified regulatory testing.

Key features of this highly efficient drug screening solution include:

• Laboratory Accuracy: Engineered to deliver precise and reliable results comparable to full laboratory standards.
• Rapid Results: Provides drug detection results in minutes using a simple dip-and-read procedure.
• Excellent Stability: Designed for room temperature storage and offers a long 24-month shelf life.

Yes, the Abbott Toxicology Alere Toxicology iScreen Dip Card is engineered to deliver results with laboratory accuracy. This ensures the on-site screening results are precise and reliable, comparable to traditional laboratory standards.

This system is designed for efficient, point-of-care drug screening, offering several key advantages:

• Rapid Results: Provides drug detection results in minutes directly at the testing site.
• Simple Procedure: It utilizes a straightforward dip-and-read methodology, minimizing complex steps.
• CLIA Waived: The available Oxycodone (OXY100) single dip device configuration is CLIA Waived, simplifying regulatory compliance for point-of-care use.
• Extended Shelf Life: The product has a robust 24-month shelf life and only requires room temperature storage.

Each box of Abbott Toxicology Alere Toxicology Iscreen® Dip Cards contains 25 individual test cards.

The Abbott Toxicology iScreen Dip Card is designed for maximum logistical ease, offering both stability and longevity:

• Extended Shelf Life: The device boasts an excellent 24-month shelf life from the date of manufacture, which helps minimize product waste and simplifies long-term inventory management.
• Convenient Storage: It is specifically engineered for room temperature storage, eliminating the need for specialized refrigeration or complex cold-chain handling.

Yes, the Abbott Toxicology iScreen Dip Card is engineered for maximum efficiency in on-site screening, utilizing a simple and fast process.

The key benefits of this testing procedure include:

• Simple Dip-and-Read Method: The test uses a straightforward dip-and-read methodology, simplifying the process and eliminating the need for complex laboratory equipment.
• Rapid On-Site Results: Results are delivered quickly, typically within minutes, enabling immediate decision-making.
• Laboratory Accuracy: Despite the speed and simplicity, the device is engineered to provide results comparable to laboratory accuracy standards.
• CLIA Waived: This specific configuration (Oxycodone OXY100) is CLIA Waived, making it suitable for a wide range of professional and point-of-care settings.
• Convenient Storage: The dip cards have an extended 24-month shelf life and require only room temperature storage, simplifying logistics.

The Abbott Toxicology Alere Toxicology iScreen Dip Card is designed for rapid, on-site substance screening in professional environments where immediate, lab-accurate results are essential. It provides results within minutes, saving both time and cost.

It is ideally suited for:

• Workplace drug testing programs.
• Clinical settings (such as urgent care facilities).
• Occupational health clinics.

Note: This specific variant is CLIA Waived and configured to screen for Oxycodone (OXY100).

Yes, the Abbott iScreen Dx Dip Card is specifically configured as a single-dip device for straightforward, rapid, on-site drug screening.

This specific variant provides excellent benefits for testing professionals:

• Targeted Detection: Screens exclusively for Oxycodone (OXY100).
• High Accuracy: Engineered to provide laboratory-accurate results quickly (available within minutes).
• Regulatory Compliance: This configuration is CLIA Waived, making it suitable for point-of-care testing environments.
• Convenience: Designed for simple room temperature storage and features an extended 24-month shelf life.
• Packaging: Supplied in boxes containing 25 individual dip cards.

Yes, the Abbott Toxicology iScreen Dip Card is designed specifically for rapid, on-site screening, providing high-quality results in minutes. This speed is a major selling point, helping to save both time and operational costs.Key benefits related to quick testing include:* Speed: Delivers laboratory-accurate results quickly, directly at the point of collection.* Simplicity: Testing uses a straightforward dip-and-read procedure, minimizing complexity and processing time for personnel.* Accuracy: Despite the rapid turnaround, the results maintain laboratory-accurate standards.* Compliance: The specific Oxycodone (OXY100) single dip device configuration is CLIA Waived, making it suitable for immediate use in various non-laboratory settings.